Reversible painful oral mucosal hyperpigmentation following palifermin administration.
Kaloyannidis
Panayotis
P
Hematology Department, Bone Marrow Transplantation Unit, George Papanicolaou Hospital, Thessaloniki, Greece. pkaloyannidis@yahoo.gr
Papalexandri
Apostolia
A
Papaemanouil
Evangelia
E
Papaioannou
Maria
M
Sakellari
Ioanna
I
D051523:Fibroblast Growth Factor 7 / Q000008:administration & dosage / Q000009:adverse effects*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017495:Hyperpigmentation / Q000209:etiology* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects* / Q000473:pathology*; D009101:Multiple Myeloma / Q000628:therapy; D010146:Pain / Q000209:etiology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D013280:Stomatitis / Q000517:prevention & control
D011994:Recombinant Proteins; D051523:Fibroblast Growth Factor 7